ENDRA LIFE SCIENCES INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.2897 USD | -0.48% |
|
-4.07% | -86.33% |
| 05-10 | ENDRA Life Sciences Inc. Provides Earnings Guidance for the Quarter Ended March 31, 2024 | CI |
| 03-28 | Transcript : ENDRA Life Sciences Inc., Q4 2023 Earnings Call, Mar 28, 2024 |
Evolution of the average Target Price on ENDRA Life Sciences Inc.
Price target over the last 5 years
History of analyst recommendation changes
7761d622cc4b27d07bf8af2584184696.30diC_Kie5c2Cee6bOJdYwr7yPnlPG5mSWHsqcAetcQ.lB1SY4HyCsFURtWCHIxtAGaPoM69UAArD1SV-_h38qCVDTYyivQZ-U5P1w~ca09df59eed6c93d1574570835499942
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.2897
USD
Average target price
10
USD
Spread / Average Target
+3,351.85%
High Price Target
10
USD
Spread / Highest target
+3,351.85%
Low Price Target
10
USD
Spread / Lowest Target
+3,351.85%
Consensus detail
Consensus revision (last 18 months)
Analysts covering ENDRA Life Sciences Inc.
| HC Wainwright |
EPS Revisions
- Stock Market
- Equities
- NDRA Stock
- Consensus ENDRA Life Sciences Inc.